Detection of TERT promoter mutations in circulating tumour DNA of patients with hepatocellular carcinoma is associated with shorter survival and proposed as useful biomarker of poor prognosis in patients with advanced liver cancers (Pezzuto et al., 2018; Ge et al., 2021; Hirai et al., 2021). The gene discussed is TERT; the disease is hepatocellular carcinoma.